Considering with or maybe even without the use of checkpoints the technology is applicable to all solid tumors resectable or not. That is before we get into infectious diseases. I don't know, what is 6 times multiple billion dollars sales expectations?
I would say if the data is good we will see 5 plus in the interim. Maybe 12. If approved and they start talking about other indications 25.
Shorts could be in for unlimited losses because eventually the sky is the limit on this one.
News 
Market Data 
Discover 
AI
